T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.28% |
| 2 | Consumer Discretionary | 14.05% |
| 3 | Financials | 13.42% |
| 4 | Industrials | 12.52% |
| 5 | Technology | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Jefferies Financial Group
JEF
$12.8B
| $11.6M | ﹤0.01% |
576,068
+34,157
| +6% | +$705K |
|
|
TGNA
1277
DELISTED
TEGNA Inc
TGNA
| $11.6M | ﹤0.01% |
691,562
| – | – |
|
|
FTR
1278
DELISTED
Frontier Communications Corp.
FTR
| $11.5M | ﹤0.01% |
115,323
+33
| +0% | +$3.23K |
|
1279
Pultegroup
PHM
$24.7B
| $11.5M | ﹤0.01% |
537,012
-4,500
| -0.8% | -$89.8K |
|
|
SWI
1280
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $11.5M | ﹤0.01% |
231,000
+24,200
| +12% | +$1.15M |
|
|
KYTH
1281
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $11.5M | ﹤0.01% |
331,213
| – | – |
|
1282
TotalEnergies
TTE
$195B
| $11.4M | ﹤0.01% |
141,446,903,990
+139,071,369,857
| +5,854% | +$13.9M |
|
1283
RE/MAX Holdings
RMAX
$279M
| $11.4M | ﹤0.01% |
333,030
-160,210
| -32% | -$5.2M |
|
|
DST
1284
DELISTED
DST Systems Inc.
DST
| $11.4M | ﹤0.01% |
242,126
+15,800
| +7% | +$740K |
|
|
PGI
1285
DELISTED
PREMIERE GLOBAL SERVICES, INC.
PGI
| $11.3M | ﹤0.01% |
1,063,572
-2,458,078
| -70% | -$26.7M |
|
|
KW
1286
DELISTED
Kennedy-Wilson Holdings
KW
| $11.3M | ﹤0.01% |
446,343
+17,200
| +4% | +$442K |
|
|
FPRX
1287
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $11.3M | ﹤0.01% |
417,610
+166,795
| +67% | +$2.87M |
|
1288
Aspen Aerogels
ASPN
$495M
| $11.2M | ﹤0.01% |
1,407,920
+1,100
| +0.1% | +$9.34K |
|
|
YELL
1289
DELISTED
Yellow Corporation Common Stock
YELL
| $11.2M | ﹤0.01% |
499,050
+89,550
| +22% | +$1.92M |
|
|
ECHO
1290
EchoStar
ECHO
$26.4B
| $11.2M | ﹤0.01% |
263,489
+741
| +0.3% | +$29.5K |
|
|
WBMD
1291
DELISTED
WebMD Health Corp.
WBMD
| $11.2M | ﹤0.01% |
283,346
+7,076
| +3% | +$272K |
|
|
HZNP
1292
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $11.2M | ﹤0.01% |
866,700
-17,400
| -2% | -$218K |
|
1293
Diageo
DEO
$53.2B
| $11.1M | ﹤0.01% |
97,115
+10,300
| +12% | +$1.2M |
|
|
CDK
1294
DELISTED
CDK Global, Inc.
CDK
| $11M | ﹤0.01% |
+270,268
| New | +$9.57M |
|
|
JMP
1295
DELISTED
JMP Group LLC
JMP
| $11M | ﹤0.01% |
1,445,412
-108,500
| -7% | -$777K |
|
|
RSPP
1296
DELISTED
RSP Permian, Inc.
RSPP
| $11M | ﹤0.01% |
437,280
-256,270
| -37% | -$6.3M |
|
1297
MaxLinear
MXL
$7.48B
| $10.9M | ﹤0.01% |
1,475,130
+1,200
| +0.1% | +$8.57K |
|
|
GRMN
1298
Garmin
GRMN
$60.3B
| $10.9M | ﹤0.01% |
206,600
+21,510
| +12% | +$1.17M |
|
1299
Williams-Sonoma
WSM
$28.6B
| $10.9M | ﹤0.01% |
288,400
-1,600
| -0.6% | -$55.5K |
|
|
FCH
1300
DELISTED
Felcor Lodging Trust
FCH
| $10.9M | ﹤0.01% |
1,007,848
+112,100
| +13% | +$1.15M |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.